Boehringer Ingelheim launches AI centre for pharma research in London

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator

Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI & ML in the UK.

Boehringer Ingelheim launches AI centre for pharma research in London

April 20 (Reuters) – German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning in London, it said ​on Monday, as it seeks to expand ‌its AI capabilities in pharmaceutical research and development. Drugmakers are increasingly turning to AI to reduce the most time-consuming aspects of drug development, from trial recruitment and site ‌selection ​to regulatory paperwork, even as ⁠industry leaders a…

Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter

Boehringer is expanding its global Computational Innovation footprint with a new center dedicated to AI and machine learning (ML) in the UKEstablishing a presence in King’s Cross, London, places Boehringer at the heart of AI and life sciences innovation, providing…

Boehringer Ingelheim to expand its AI footprint in UK, in £150M investment

LONDON – Boehringer Ingelheim is growing its artificial intelligence arm to the UK by building a new hub in central London and investing £150 million over the next 10 years. The AI hub will be ...

Boehringer Ingelheim launches AI centre in London - Pharmaceutical Technology

The new site will focus on the use of AI models for purposes including the discovery and development of targeted medicines for patients with unmet medical needs.

Boehringer Ingelheim launches AI centre in London

The new site will focus on the use of AI models for purposes including the discovery and development of targeted medicines for patients with unmet medical needs.The post Boehringer Ingelheim launches AI centre in London appeared first on Medical Device Network.